ELI LILLY & Co is 387.3x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($1.070 T vs $2.76 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLNO | LLY |
|---|---|---|
| Market cap | $2.76 B | $1.070 T |
| US-listed rank | #1882 | #10 |
| Revenue (latest FY) | $190.41M | $65.18B |
| Net income (latest FY) | $20.89M | $20.64B |
| Net margin | 11.0% | 31.7% |
| P/E (trailing FY) | 132.3 | 51.8 |
| SEC filings | 1,119 | 989 |
ELI LILLY & Co is 387.3x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($1.070 T vs $2.76 B).
In their latest fiscal years, SOLENO THERAPEUTICS INC reported $190.41M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: SOLENO THERAPEUTICS INC and ELI LILLY & Co, or browse the full rankings.